Finasteride Travel & Timezone-Shift Protocols

What the label specifies

For hair loss, Propecia is one 1 mg tablet once daily, with or without meals, and daily use for three months or more is usually needed before benefit is seen [1]. The dosing section does not tie the dose to a time of day. Bioavailability averages about 65% and is not affected by food, and plasma levels peak 1 to 2 hours after a tablet [1]. Proscar, the 5 mg tablet for BPH, is one tablet once daily [2]. Finasteride is prescription-only in the United States [5].

The half-life is short; the effect is not

Finasteride's mean terminal half-life is about 5 to 6 hours in men aged 18 to 60 and about 8 hours in men over 70 [1]. That figure describes the plasma curve only. The drug forms a stable complex with Type II 5-alpha-reductase whose turnover is extremely slow, with a half-life of approximately 30 days, so the effect on DHT outlasts the plasma half-life; 65% suppression of serum DHT is reached within 24 hours of a 1 mg tablet [1].

Eastbound, westbound, and long-haul

We found no published study that tested a deliberately shifted finasteride dosing schedule in travelers.

Missed doses and stopping

Propecia's dosing section does not include a missed-dose instruction [1]. It says continued use is recommended to sustain benefit and that withdrawal of treatment leads to reversal of effect within 12 months [1]. In two 1-year placebo-controlled trials of 1,553 men aged 18 to 41, hair count in a 5.1 cm2 circle of vertex scalp was 107 hairs higher than placebo at one year and 138 higher at two years (P<0.001), and the placebo group kept losing hair [4].

Medicines picked up on the road

The label reports that no drug interactions of clinical importance have been identified and that finasteride does not appear to affect the cytochrome P450 system; antipyrine, digoxin, propranolol, theophylline and warfarin were tested with no clinically meaningful interactions [1]. Finasteride was also used alongside acetaminophen, aspirin, alpha-blockers, ACE inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium channel blockers, diuretics, NSAIDs and quinolone anti-infectives in clinical studies without evidence of clinically significant adverse interactions [1].

Finasteride is itself metabolized mainly by CYP3A4, but the label's interaction section does not discuss CYP3A4 inhibitors or inducers [1]. Doxycycline, mefloquine and atovaquone-proguanil are not among the compounds named in that section, so the label makes no statement about them [1].

Coated tablets and a pregnant partner

The tablets are coated, and the coating prevents contact with the active ingredient during normal handling as long as the tablets have not been broken or crushed [1]. The label states that women who are pregnant or may become pregnant should not handle crushed or broken tablets because of the risk of abnormal development of the external genitalia in a male fetus, and that if contact occurs the area should be washed immediately with soap and water [1]. Finasteride is contraindicated in women who are pregnant or may become pregnant [1].

Anti-doping rules

Finasteride and dutasteride are not named anywhere in the World Anti-Doping Agency's 2026 Prohibited List, including the S5 section covering diuretics and masking agents [3].